Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Consolidations in biotechnology

Abstract

Biotechnology mergers and acquisitions are gaining momentum, but may not always lead to a financial windfall.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. McCafferty, J. April 1998. CFO 44–52.

  2. Persidis, A. 1998. Nat. Biotechnol. 16: 981– 983.

  3. Hamilton, J.O.C. 1998. Recombinant Capital. http://www.recap.com.

  4. James, B.G. 1998. Decision Resources, PharmVision 2005.

  5. Champsi, F.H. 1998. Nat. Biotechnol. (Bioentrepre-neurship Suppl.)16: 61–62.

    Article  Google Scholar 

  6. Esposito, R.S. and Ostro, M.J. 1998. Nat. Biotechnol. (Bioentrepreneurship Suppl.) 16: 63.

  7. Bernstein K. et al.1998.BioCentury 6/54: A1–A6.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Persidis, A. Consolidations in biotechnology. Nat Biotechnol 17, BE3–BE4 (1999). https://doi.org/10.1038/4624

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/4624

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing